Group sales amounted to EUR 4.3 billion, with a 5% comparable sales decline, in line with the update provided on October 12, 2022 Comparable order intake decreased 6% on the back of 47% growth in Q3 ...
Group sales increased to EUR 4.2 billion, with 6% comparable sales growth Comparable order intake growth was flat, with double-digit growth in the Diagnosis & Treatment businesses, offset by a decline ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback